Capítulos de Libro (15) Publicaciones en las que ha participado algún/a investigador/a

2023

  1. Co-administration of DL-3-n-butylphthalide and neprilysin is neuroprotective in Alzheimer disease associated with mild traumatic brain injury

    International Review of Neurobiology (Academic Press Inc.), pp. 145-185

  2. Co-administration of Nanowired DL-3-n-Butylphthalide (DL-NBP) Together with Mesenchymal Stem Cells, Monoclonal Antibodies to Alpha Synuclein and TDP-43 (TAR DNA-Binding Protein 43) Enhance Superior Neuroprotection in Parkinson’s Disease Following Concussive Head Injury

    Advances in Neurobiology (Springer), pp. 97-138

  3. Effects of curcumin nanodelivery on schizophrenia and glioblastoma

    International Review of Neurobiology (Academic Press Inc.), pp. 163-203

  4. Efficacy of invasive and non-invasive methods for the treatment of Parkinson's disease: Nanodelivery and enriched environment

    International Review of Neurobiology (Academic Press Inc.), pp. 103-143

  5. Methods to study primary cilia and autophagy in the brain

    Methods in Cell Biology (Academic Press Inc.), pp. 217-234

  6. Nanodelivery of histamine H3 receptor inverse agonist BF-2649 with H3 receptor antagonist and H4 receptor agonist clobenpropit induced neuroprotection is potentiated by antioxidant compound H-290/51 in spinal cord injury

    International Review of Neurobiology (Academic Press Inc.), pp. 37-77

  7. Nanowired delivery of DL-3-n-butylphthalide with antibodies to alpha synuclein potentiated neuroprotection in Parkinson's disease with emotional stress

    International Review of Neurobiology (Academic Press Inc.), pp. 47-82

  8. Nanowired delivery of antibodies to tau and neuronal nitric oxide synthase together with cerebrolysin attenuates traumatic brain injury induced exacerbation of brain pathology in Parkinson's disease

    International Review of Neurobiology (Academic Press Inc.), pp. 83-121

  9. Neuroprotective Effects of Nanowired Delivery of Cerebrolysin with Mesenchymal Stem Cells and Monoclonal Antibodies to Neuronal Nitric Oxide Synthase in Brain Pathology Following Alzheimer’s Disease Exacerbated by Concussive Head Injury

    Advances in Neurobiology (Springer), pp. 139-192

  10. Nicotine neurotoxicity exacerbation following engineered Ag and Cu (50–60 nm) nanoparticles intoxication. Neuroprotection with nanowired delivery of antioxidant compound H-290/51 together with serotonin 5-HT3 receptor antagonist ondansetron

    International Review of Neurobiology (Academic Press Inc.), pp. 189-233

  11. Sleep deprivation enhances amyloid beta peptide, p-tau and serotonin in the brain: Neuroprotective effects of nanowired delivery of cerebrolysin with monoclonal antibodies to amyloid beta peptide, p-tau and serotonin

    International Review of Neurobiology (Academic Press Inc.), pp. 125-162

  12. Spastic Paraplegia Type 7 (SPG7)

    Essentials of Cerebellum and Cerebellar Disorders: A Primer For Graduate Students, Second Edition (Springer International Publishing), pp. 691-695

  13. Spinal cord injury induced exacerbation of Alzheimer's disease like pathophysiology is reduced by topical application of nanowired cerebrolysin with monoclonal antibodies to amyloid beta peptide, p-tau and tumor necrosis factor alpha

    International Review of Neurobiology (Academic Press Inc.), pp. 3-35

  14. Stress induced exacerbation of Alzheimer's disease brain pathology is thwarted by co-administration of nanowired cerebrolysin and monoclonal amyloid beta peptide antibodies with serotonin 5-HT6 receptor antagonist SB-399885

    International Review of Neurobiology (Academic Press Inc.), pp. 3-46

  15. The endocannabinoid system and autoimmune demyelination: A focus on multiple sclerosis

    Neurobiology and Physiology of the Endocannabinoid System (Elsevier), pp. 229-240